NBC Sports EDGE's Ryan Knaus dishes out his thoughts on Timberwolves rookie Anthony Edwards and why he's paying off for patient managers as of late.
NBC Sports EDGE's Ryan Knaus dishes out his thoughts on Timberwolves rookie Anthony Edwards and why he's paying off for patient managers as of late.
Our countdown of the top 100 prospects in the 2021 NFL draft rolls along with No. 22 — the Hurricanes' promising but underdeveloped defender.
RNA Therapy Market Research Report by Technology (Enabled Technologies and Enabling Technologies), by Application (Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, and Kidney Diseases), by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "RNA Therapy Market Research Report by Technology, by Application, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06012998/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The United States RNA Therapy Market is expected to grow from USD 217.31 Million in 2020 to USD 508.66 Million by the end of 2025.2. The United States RNA Therapy Market is expected to grow from EUR 190.54 Million in 2020 to EUR 446.00 Million by the end of 2025.3. The United States RNA Therapy Market is expected to grow from GBP 169.39 Million in 2020 to GBP 396.50 Million by the end of 2025.4. The United States RNA Therapy Market is expected to grow from JPY 23,192.53 Million in 2020 to JPY 54,287.27 Million by the end of 2025.5. The United States RNA Therapy Market is expected to grow from AUD 315.56 Million in 2020 to AUD 738.64 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the RNA Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:"The Enabling Technologies is projected to witness the highest growth during the forecast period"Based on Technology, the RNA Therapy Market studied across Enabled Technologies and Enabling Technologies. The Enabled Technologies further studied across Inhibition, Labeling, Linear amplification, Microarrays, Purification, and qRT-PCR. The Enabling Technologies further studied across RNA Antisense Technologies and RNA Interference Technologies. The Enabling Technologies commanded the largest size in the RNA Therapy Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period."The Retinal Diseases is projected to witness the highest growth during the forecast period"Based on Application, the RNA Therapy Market studied across Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, Kidney Diseases, Metabolic Disorders, Oncology, and Retinal Diseases. The Infectious Diseases commanded the largest size in the RNA Therapy Market in 2020. On the other hand, the Retinal Diseases is expected to grow at the fastest CAGR during the forecast period."The Diagnostics is projected to witness the highest growth during the forecast period"Based on End User, the RNA Therapy Market studied across Academic Research, Diagnostics, and Drug Discovery & Development. The Drug Discovery & Development commanded the largest size in the RNA Therapy Market in 2020. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.360iResearch™ FPNV Positioning Matrix:The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.360iResearch™ Competitive Strategic Window:The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the United States RNA Therapy Market?2. What are the inhibiting factors and impact of COVID-19 shaping the United States RNA Therapy Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States RNA Therapy Market?4. What is the competitive strategic window for opportunities in the United States RNA Therapy Market?5. What are the technology trends and regulatory frameworks in the United States RNA Therapy Market?6. What are the modes and strategic moves considered suitable for entering the United States RNA Therapy Market?Read the full report: https://www.reportlinker.com/p06012998/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Former Brooklyn Center police officer Kim Potter resigned after the death of Daunte Wright. A decision whether to charge her could come Wednesday.
(Bloomberg) -- European Union governments reached a deal on technical standards for so-called vaccine passports, advancing the effort to boost travel to and within the bloc in time for the summer season.Envoys meeting in Brussels agreed to support a draft legal text setting out specifics for “digital green certificates,” according to an EU statement Wednesday. The documents will provide proof their holders have been vaccinated against the coronavirus, tested negative or have recently recovered from the disease and are considered immune.Negotiations between the governments and the European Parliament are expected soon after the parliament formalizes its position by April, the statement, which confirms an earlier Bloomberg report. The deal could allow the resumption of hassle-free travel, without quarantine requirements, for vaccine-pass holders by June. Airlines and industry groups have already introduced apps that are capable of incorporating information on tests and vaccine status.European travel and leisure stocks have gained 20% this year on the expectation that an accelerating vaccine rollout will pave the way for normal travel patterns after a yearlong slump in air traffic and hotel-stays induced by the pandemic.People vaccinated before the new rules take effect will be entitled to the passes, according to the draft. Those who contract the disease should be recognized as immune from day 11 for about six months.Governments are “encouraged” to accept all vaccines that have secured World Health Organization approval for emergency use and should recognize certificates issued by non-EU nations, the plan says -- a key to resuming incoming travel from outside the bloc.Vaccine DeliveriesThe success of the vaccine certificates initiative is contingent on inoculating the bulk of the EU’s population by summer. While the region has lagged behind the U.S. and the U.K., the pace of jabs has been accelerating.Pfizer Inc. and BioNTech SE said they expect to deliver more Covid-19 vaccines to the EU this quarter than currently targeted, after deliveries of Johnson & Johnson’s shot were paused.Pfizer said it’s “on track to significantly exceed established commitments” by the end of June. The EU is expecting some 200 million doses from the U.S. drugmaker and its German partner, up from about 66 million in the first three months of the year.Faster deliveries could help to somewhat offset delays linked to the J&J halt. U.S. regulators on Tuesday recommended pausing vaccinations with the J&J shot while they review rare cases of potentially deadly brain clots, similar to those seen with AstraZeneca Plc’s vaccine.(Updates with announcement of deal from second paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Hopes that the great British getaway would be possible this summer grew on Wednesday, with easyJet predicting that most of Europe would be open for travel and British Airways confident on routes to the U.S., despite ongoing uncertainty. Europe's travel industry, battered by the pandemic, is counting on British holidaymakers to lead a tourism rebound this summer. But over the last month, a third wave of coronavirus infections in continental Europe has cast doubts on the bumper return of travel.
Nymbus expands its leadership team with three newly appointed top female executives.
Buddy Valastro provided an update on the "Rachael Ray Show" about his right hand and says he is "feeling good" after his fifth surgery.
Industry veteran Wahid Nawabi, president and CEO of AeroVironment, will serve as Chairman to provide strategic counsel along with other prominent board membersBOSTON, April 14, 2021 (GLOBE NEWSWIRE) -- LiquidStack, the world’s largest liquid cooling company, today announced the formation of its board of directors. Wahid Nawabi, president and CEO of AeroVironment Inc., will serve as Chairman of the Board and Joe Capes, co-founder and CEO of LiquidStack, will serve as Executive Director. Dr. Sunlai Chang, president of Wiwynn, Stijn Ehren, international tax counsel at the Bitfury Group, and Valery Vavilov, co-founder and CEO of Bitfury, will serve as non-executive Directors, effective immediately. The new board members are industry veterans spanning high-performance computing, Blockchain technology, data center infrastructure, information technology, manufacturing, tax, finance and government relations. Together, they will provide strategic counsel on LiquidStack’s business, growth and global potential. The LiquidStack board is composed of five members, four of whom are independent. Wahid Nawabi will bring his extensive experience in launching new products to bear for LiquidStack as the company looks to expand in data centers, edge and high performance computing across the globe. At AeroVironment, Wahid led the integration of the company’s engineering, operations, supply chain and quality functional organizations into a single corporate shared services model - driving significant improvements in customer satisfaction and operational efficiency. During his tenure at American Power Conversion Corporation (APC), Wahid played a key role in launching the company’s ambitious and successful strategy of entering the data center critical power and cooling infrastructure business. He helped grow the company from $50 million to more than $2.4 billion in annual revenue, which resulted in APC’s eventual sale to Schneider Electric for $6.1 billion (the largest acquisition in the history of Schneider Electric). As Chairman of the Board, Wahid will support LiquidStack’s global growth plans and ambitions. “After a 16-year career in power and cooling, I am confident that the future of the data center industry is 2-phase immersion cooling. I could not be more excited to serve as Chairman of the Board for LiquidStack, the original pioneer of immersion cooling technology,” said Wahid Nawabi, president and CEO of AeroVironment. Dr. Sunlai Chang has more than two decades of product development experience from data center IT infrastructure, automation, defense, semiconductor equipment and IT software industries. As president and board member of Wiwynn, LiquidStack’s Series A investor, Sunlai will work closely with the LiquidStack team to deliver state of the art cooling equipment for data centers. He will flex his experience with product development, product architecture, supply chain, manufacturing, quality engineering and business automation. “We envision the increasing adoption of the two-phase immersion cooling technology in data centers,” said Dr. Sunlai Chang, president of Wiwynn. ”Following our Series A investment in LiquidStack, we look forward to deepening and strengthening our partnership. It’s my pleasure to join the board to work with LiquidStack’s seasoned leadership team for rapid growth and expansion.” Joe Capes has deep roots in the cooling industry. Prior to his current role, Joe was Global Director of Cooling Offer Development for Schneider Electric’s Cloud & Service Provider segment, providing tailored solutions for the world’s largest data center owners and operators. During his 19 years with the company, he globalized Schneider Electric’s data center cooling business in Europe, Asia and Latin America which helped lead to the company’s success as a top manufacturer of mission-critical cooling equipment. As Executive Director of the board, Joe will lead LiquidStack to scale next generation cooling for compute-intensive applications and the infrastructure supporting them. “We are pleased to welcome Wahid, Sunlai, Stijn and Valery to the LiquidStack board,” said Joe Capes, co-founder and CEO of LiquidStack. “As Board Chairman, Wahid brings significant experience in manufacturing, supply chain, rapid revenue growth, public offerings, and mergers and acquisitions that will help propel the company forward.” Stijn Ehren will bring his tax law expertise to the LiquidStack board. Stijn started his career in 1994 at Arthur Andersen in Amsterdam as an international tax advisor, before serving as tax manager for Cisco Systems in Amsterdam and Singapore. Since then, he has led international tax functions for established pharmaceutical companies, including Akzo Nobel and Merck. Today, he serves as international tax counsel at the Bitfury Group. Valery Vavilov has long been a proponent of liquid cooling, deploying the first and largest immersion-cooled data centers using LiquidStack’s 2-phase immersion technology. Bitfury incubated LiquidStack for five years, deploying hyperscale volumes of product with a laser focus on liquid cooling for Blockchain technology applications. Now that LiquidStack has launched as an independent company, it will continue to have a close partnership with Bitfury. Through cross-licensing arrangement, the companies are already collaborating on new liquid cooling projects related to crypto-mining and artificial intelligence. For more information on the LiquidStack board of directors, please visit www.liquidstack.com/about-us. About LiquidStackLiquidStack has the world’s largest footprint of liquid cooling for data center, edge and high-performance computing. LiquidStack’s 2-phase immersion liquid cooling is the only proven, highly scalable, environmentally safe and sustainable solution to meet the growing thermal challenges of cloud, enterprise, 5G and edge computing applications. Since pioneering 2-phase immersion cooling in 2012, LiquidStack has been deploying advanced cooling solutions across the world’s most demanding compute environments, actively reducing energy and water use dependencies on a massive scale. Today, LiquidStack provides thermal management solutions to many of the world’s largest cloud services, semiconductor, manufacturing and IT hardware providers. To learn more, please visit www.liquidstack.com. Media Contact:Kelsey DielmanScratch Marketing + Media for LiquidStackkelsey@scratchmm.com
The "Global E-cigarette Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
While QBs are expected to quickly come off the board, there is less clarity with the defensive talent at the top of this year's NFL draft.
Westlake, Louisiana--(Newsfile Corp. - April 14, 2021) - Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of PainplexTM an all-herbal extraction developed by Gold River Productions Services (GRPS) and other formulations. This will be part of the "Relief Kit" which will include products from both ...
Amazon knocks the price of the Fire TV Stick Lite streaming dongle down to $20 for Prime members.
Shonda Rhimes is shocked that Bridgerton fans are so shocked by the news that breakout star Regé-Jean Page will not be returning for Season 2 — in part, because it’s not as if the Duke of Hastings got hit by a Seattle city bus. Netflix (via Lady Whistledown) announced earlier this month that Page won’t […]
“For all the talk of revenge spending and pent-up demand for travel... just 13 percent of stimulus check recipients plan to spend the money on discretionary activities or nonessential items," said one analyst.
Mediawan Rights, the commercial division of French independent media powerhouse Mediawan founded by Pierre-Antoine Capton, Xavier Niel and Matthieu Pigasse in 2015, is poised to step up its premium documentary clout with the launch of a dedicated sales unit. Presided by veteran sales executive Valerie Vleeschhouwer, Mediawan Rights has signed an exclusive partnership deal with […]
LOGANSPORT, Ind., April 14, 2021 (GLOBE NEWSWIRE) -- Logansport Financial Corp., (OTCBB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended March 31, 2021 of $934,000 or $1.52 per diluted share, compared to earnings in 2020 of $613,000 or $1.00 per diluted share. The Dividends paid to shareholders were $0.40 per share in the first quarter of 2021. Total loans were $137.7 million on March 31, 2021 compared to $135.0 million on December 31, 2020. Deposits were $213.0 million on March 31, 2021 compared to $189.5 million on December 31, 2020. Total assets on March 31, 2021 were $243.0 million compared to $220.4 million on December 31, 2020. Total Shareholders’ Equity on March 31, 2021 was $28.5 million compared to $25.1 million on March 31, 2020. The statements contained in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involves a number of risks and uncertainties. A number of factors could cause results to differ materially from the objectives and estimates expressed in such forward-looking statements. These factors include, but are not limited to, changes in the financial condition of issuers of the Company’s investments and borrowers, changes in economic conditions in the Company’s market area, changes in policies of regulatory agencies, fluctuations in interest rates, demand for loans in the Company’s market area, changes in the position of banking regulators on the adequacy of our allowance for loan losses, and competition, all or some of which could cause actual results to differ materially from historical earnings and those presently anticipated or projected. These factors should be considered in evaluation of any forward-looking statements, and undue reliance should not be placed on such statements. The Company does not undertake and specifically disclaims any obligation to update any forward-looking statements to reflect occurrence of anticipated or unanticipated events or circumstances after the date of such statements. LOGANSPORT FINANCIAL CORP. SELECTED FINANCIAL DATA (Dollars in thousands, except for share data) 03/31/21 12/31/20 Total assets $243,020 $220,365 Loans receivable, net 137,827 134,996Allowance for loan losses 1,946 1,872Cash and cash equivalents 37,510 17,430Securities available for sale 29,402 29,388Investment in Logansport Investments, Inc. 31,724 29,739Federal Home Loan Bank stock 1,247 731Deposits 213,052 189,476Borrowings - -Shareholders’ equity 28,462 28,451Shares O/S end of period 612,887 611,863Nonperforming loans 165 451Real estate owned 233 - Three months ended 03/31 2021 2020 Interest income (including Logansport Investments, Inc.) $2,111 $2,035Interest expense 151 311Net interest income 1,782 1,724Provision for loan losses 64 -Net interest income after provision 1,896 1,724Gain (Loss) on sale of investments - -Gain on sale of loans 440 51Gain (Loss) on sale of REO - -Total other income 282 214General, admin. & other expense 1,478 1,265Earnings before income taxes 1,140 724Income tax expense 206 111Net earnings $934 $613Basic earnings per share $1.52 $1.00Diluted earnings per share $1.52 $1.00Weighted avg. shares o/s-diluted 612,887 611,863 Contact: Chad HigginsChief Financial OfficerPhone-574-722-3855Fax-574-722-3857
NASCAR’s Cup Series race at Darlington in May will be called the Goodyear 400.
Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize a botulinum toxin (DTX-021) in the United States and Canada.
beqom, provider of cloud-based compensation management software, announced that Microsoft has designated beqom as an eligible "Microsoft Transact" application for customers of the Microsoft Azure cloud platform. This means that Azure customers can use their existing Azure budget commitment to fund the purchase of the beqom compensation management solution.
Technavio has monitored the electric breast pumps market in its latest market research report. The market is poised to garner USD 276.75 million and accelerate at a CAGR of almost 8% during the forecast period. This healthcare equipment report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.